Guanfacine Extended-release for Adolescents With Cannabis Use
Status:
RECRUITING
Trial end date:
2026-06-30
Target enrollment:
Participant gender:
Summary
A randomized controlled trial to assess the efficacy of extended-release guanfacine to reduce cannabis use frequency in young people with cannabis use disorder following a period of monitored abstinence.
Phase:
PHASE2
Details
Lead Sponsor:
Orygen
Collaborators:
University of Melbourne Youth Support and Advocacy Service